Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R17.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R21.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R23.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R12.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R24.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R11.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R25.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R15.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R5.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R10.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - CHEMBIO DIAGNOSTICS, INC.R22.htm


 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________

FORM 10 - Q/A
Amendment No. 1
_______________________________

 [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
For the quarterly period ended September 30, 2012
 
OR
 
[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from: ______ to ________

000-30379
(Commission File Number)
 
 
Chembio Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
 
88-0425691
(State or other jurisdiction of incorporation)
 
(IRS Employer Identification Number)
3661 Horseblock Road
Medford, New York 11763
(Address of principal executive offices including zip code)
(631) 924-1135
(Registrant’s telephone number, including area code)
___N/A___
(Former Name or Former Address, if Changed Since Last Report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes   X   No ___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).         Yes_X__     No    

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
             Large accelerated filer [ ]                                        Accelerated filer [ ]         
             Non-accelerated filer [ ]                                          Smaller reporting company [X] 
          (Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ____ No   X  

As of  November 9, 2012, the Registrant had 8,007,168 shares outstanding of its $.01 par value common stock.


 
 
 

 
EXPLANITORY NOTE
 

 
This Amendment No. 1 to Form 10-Q amends the Form 10-Q filed by Chembio Diagnostics, Inc. (the “Company”) with the Securities and Exchange Commission (“SEC”) on November 13, 2012 to include XBRL documents to correct their inadvertent omission in the earlier filing.
 
 

 
EXHIBITS INDEX
 Number  
      Description                                                                                                                     
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
     



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Chembio Diagnostics, Inc.

Date:
November 3, 2011
By: /s/ Lawrence A. Siebert
   
Lawrence A. Siebert
   
Chief Executive Officer
(Principal Executive Officer)
     
Date:
November 3, 2011
By: /s / Richard J. Larkin
   
Richard J. Larkin
   
Chief Financial Officer
(Principal Financial and Accounting Officer)